Isomorphic Labs is an AI-driven company specializing in drug design and development. The company leverages advanced artificial intelligence research to enhance its drug design engine and expand its pipeline of drug candidates.
Estimated Valuation
Leadership & Board
Key Executives
Chief Executive OfficerDemis Hassabis
Chief Medical OfficerBeni Wolf
Chief Technology OfficerSergei Yakneen
Current Number of Employees433
Current LinkedIn Followers105,215
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$3B
Total Amount Raised$3B
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$2B
Latest Funding Amount$2B
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Isomorphic Labs had 433 employees as of September 7, 2026. The number of employees increased by 1 (0.23%) week-over-week.
433Latest Employee Count
1(0.23%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Isomorphic Labs had 105,215 followers as of September 7, 2026. The number of followers increased by 626 (0.60%) week-over-week.
105,215Latest Followers Count
626(0.60%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Aug 20, 2026
Series B
$2.10B
―
Mar 31, 2025
Series A
$600.00M
―
Investors
Series A
Series A
Series A
Series B
Series B
Series B
Series B
Series B
Similar Companies
A snapshot of private companies similar to Isomorphic Labs, helping you discover and navigate related company profiles.
